Impact of the COVID-19 pandemic on hyperacute stroke treatment: Experience from a comprehensive stroke centre in singapore
2021
Background: The Coronavirus disease 2019 (COVID-19) pandemic is rapidly evolving and affecting healthcare systems across the world Singapore has escalated its alert level to Disease Outbreak Response System Condition (DORSCON) Orange, signifying severe disease with community spread Objectives: We aimed to study the overall volume of AIS cases and the delivery of hyperacute stroke services during DORSCON Orange Methods: This was a single-centre, observational cohort study performed at a comprehensive stroke centre responsible for AIS cases in the western region of Singapore, as well as providing care for COVID-19 patients All AIS patients reviewed as an acute stroke activation in the Emergency Department (ED) from November 2019 to April 2020 were included System processes timings, treatment and clinical outcome variables were collected Results: We studied 350 AIS activation patients admitted through the ED, 206 (58 9%) pre- and 144 during DORSCON Orange Across the study period, number of stroke activations showed significant decline (p =0 004, 95% CI 6 513 - -2 287), as the number of COVID-19 cases increased exponentially, whilst proportion of activations receiving acute recanalization therapy remained stable (p = 0 519, 95% CI -1 605 - 2 702) Amongst AIS patients that received acute recanalization therapy, early neurological outcomes in terms of change in median NIHSS at 24 hours (-4 versus -4, p = 0 685) were largely similar between the pre- and during DORSCON orange periods Conclusions: The number of stroke activations decreased while the proportion receiving acute recanalization therapy remained stable in the current COVID-19 pandemic in Singapore (Figure Presented)
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
8
Citations
NaN
KQI